As previously mentioned, because DPP-4 inhibitors can increase the risk of hypoglycemia when added to insulin or a sulfonylurea, a dose decrease of sulfonylurea and/or insulin should be considered prior to initiation of a DPP-4 inhibitor
Semaglutide use is increasingly associated with gastroparesis, a condition marked by delayed gastric emptying, causing nausea, vomiting, abdominal pain, bloating, satiety, acid reflux, and blood sugar fluctuations
The spices turmeric, cumin, coriander, cinnamon, and ginger delivered a vibrant flavor profile
Having accountability partners significantly increases success rates and provides motivation during challenging periods
No dosage adjustment is needed for patients with renal impairment, though renal function should be monitored in patients experiencing severe adverse gastrointestinal reactions